Attribute,Value
Symbol,ABBV
Name,AbbVie Inc.
Industry,Drug Manufacturers - General
Sector,Healthcare
Country,United States
Market Cap,325052923904
Description,"AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Beh√ßet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."
Website,https://www.abbvie.com
Full Time Employees,55000
Currency,USD
Previous Close,181.68
Open,181.3
Bid,182.03
Ask,184.0
Day's Range,180.52 - 184.07
52 Week Range,153.58 - 218.66
Volume,4923456
Avg. Volume,8130253
Market Cap (intraday),325052923904
Beta (5Y Monthly),0.551
PE Ratio (TTM),78.64103
EPS (TTM),2.34
Earnings Date,1745581383
Forward Dividend & Yield,6.56 (3.56)
Ex-Dividend Date,1744675200
1y Target Est,210.56705
